Showing 1 - 17 results of 17 for search 'Milena Casula', query time: 0.07s
Refine Results
-
1
-
2
-
3
Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy? by Giuseppe Palmieri, Carla Maria Rozzo, Maria Colombino, Milena Casula, Maria Cristina Sini, Antonella Manca, Marina Pisano, Valentina Doneddu, Panagiotis Paliogiannis, Antonio Cossu
Published 2021-05-01
Article -
4
Anti-inflammatory activity of a novel family of aryl ureas compounds in an endotoxin-induced airway epithelial cell injury model. by Nuria E Cabrera-Benitez, Eduardo Pérez-Roth, Milena Casula, Angela Ramos-Nuez, Carla Ríos-Luci, Carlos Rodríguez-Gallego, Ithaisa Sologuren, Virginija Jakubkiene, Arthur S Slutsky, José M Padrón, Jesús Villar
Published 2012-01-01
Article -
5
Complete and Durable Response to Combined Chemo/Radiation Therapy in <i>EGFR</i> Wild-Type Lung Adenocarcinoma with Diffuse Brain Metastases by Davide Adriano Santeufemia, Giuseppe Palmieri, Antonio Cossu, Valli De Re, Laura Caggiari, Mariangela De Zorzi, Milena Casula, Maria Cristina Sini, Giovanni Baldino, Maria Filomena Dedola, Giuseppe Corona, Gianmaria Miolo
Published 2019-04-01
Article -
6
Correction: Anti-Inflammatory Activity of a Novel Family of Aryl Ureas Compounds in an Endotoxin-Induced Airway Epithelial Cell Injury Model. by Nuria E. Cabrera-Benitez, Eduardo Pérez-Roth, Milena Casula, Ángela Ramos-Nuez, Carla Ríos-Luci, Carlos Rodríguez-Gallego, Ithaisa Sologuren, Virginija Jakubkiene, Arthur S. Slutsky, José M. Padrón, Jesús Villar
Published 2012-01-01
Article -
7
EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma by Maria Colombino, Panagiotis Paliogiannis, Antonio Cossu, Davide Adriano Santeufemia, Sardinian Lung Cancer (SLC) Study Group, Maria Cristina Sini, Milena Casula, Grazia Palomba, Antonella Manca, Marina Pisano, Valentina Doneddu, Giuseppe Palmieri
Published 2019-11-01
Article -
8
Common variants of TLR1 associate with organ dysfunction and sustained pro-inflammatory responses during sepsis. by Maria Pino-Yanes, Almudena Corrales, Milena Casula, Jesús Blanco, Arturo Muriel, Elena Espinosa, Miguel García-Bello, Antoni Torres, Miguel Ferrer, Elizabeth Zavala, Jesús Villar, Carlos Flores, GRECIA and GEN-SEP Groups
Published 2010-01-01
Article -
9
Comparison between Three Different Techniques for the Detection of EGFR Mutations in Liquid Biopsies of Patients with Advanced Stage Lung Adenocarcinoma by Milena Casula, Marina Pisano, Panagiotis Paliogiannis, Maria Colombino, Maria Cristina Sini, Angelo Zinellu, Davide Santeufemia, Antonella Manca, Stefania Casula, Silvia Tore, Renato Lobrano, Sardinian Lung Cancer Study Group, Antonio Cossu, Giuseppe Palmieri
Published 2023-03-01
Article -
10
Comparison of <i>BRAF</i> Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients by Maria Colombino, Carla Rozzo, Panagiotis Paliogiannis, Milena Casula, Antonella Manca, Valentina Doneddu, Maria Antonietta Fedeli, Maria Cristina Sini, Grazia Palomba, Marina Pisano, Paolo A. Ascierto, Corrado Caracò, Amelia Lissia, Antonio Cossu, Giuseppe Palmieri
Published 2020-07-01
Article -
11
Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study by Panagiotis Paliogiannis, Maria Colombino, Maria Cristina Sini, Antonella Manca, Milena Casula, Grazia Palomba, Marina Pisano, Valentina Doneddu, Angelo Zinellu, Davide Santeufemia, Sardinian Lung Cancer (SLC) Study Group, Giovanni Sotgiu, Antonio Cossu, Giuseppe Palmieri
Published 2022-01-01
Article -
12
Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective by Maria Neve Ombra, Panagiotis Paliogiannis, Luigia Stefania Stucci, Maria Colombino, Milena Casula, Maria Cristina Sini, Antonella Manca, Grazia Palomba, Ignazio Stanganelli, Mario Mandalà, Sara Gandini, Amelia Lissia, Valentina Doneddu, Antonio Cossu, Giuseppe Palmieri, for the Italian Melanoma Intergroup (IMI)
Published 2019-05-01
Article -
13
The Enigmatic Role of TP53 in Germ Cell Tumours: Are We Missing Something? by Margaret Ottaviano, Emilio Francesco Giunta, Pasquale Rescigno, Ricardo Pereira Mestre, Laura Marandino, Marianna Tortora, Vittorio Riccio, Sara Parola, Milena Casula, Panagiotis Paliogiannis, Antonio Cossu, Ursula Maria Vogl, Davide Bosso, Mario Rosanova, Brunello Mazzola, Bruno Daniele, Giuseppe Palmieri, Giovannella Palmieri
Published 2021-07-01
Article -
14
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) by Irene Vanni, Milena Casula, Lorenza Pastorino, Antonella Manca, Bruna Dalmasso, Virginia Andreotti, Marina Pisano, Maria Colombino, Italian Association for Cancer Research (AIRC) Study Group, Ulrich Pfeffer, Enrica Teresa Tanda, Carla Rozzo, Panagiotis Paliogiannis, Antonio Cossu, Paola Ghiorzo, Giuseppe Palmieri, for the Italian Melanoma Intergroup (IMI)
Published 2020-12-01
Article -
15
Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study by Milena Casula, Panagiotis Paliogiannis, Fabrizio Ayala, Vincenzo De Giorgi, Ignazio Stanganelli, Mario Mandalà, Maria Colombino, Antonella Manca, Maria Cristina Sini, Corrado Caracò, Paolo Antonio Ascierto, Rosanna Rita Satta, Melanoma Unit of Sassari (MUS), Amelia Lissia, Antonio Cossu, Giuseppe Palmieri, for the Italian Melanoma Intergroup (IMI)
Published 2019-08-01
Article -
16
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients by Stefano Mariani, Marco Puzzoni, Riccardo Giampieri, Pina Ziranu, Valeria Pusceddu, Clelia Donisi, Mara Persano, Giovanna Pinna, Erika Cimbro, Alissa Parrino, Dario Spanu, Andrea Pretta, Eleonora Lai, Nicole Liscia, Alessio Lupi, Enrica Giglio, Grazia Palomba, Milena Casula, Marina Pisano, Giuseppe Palmieri, Mario Scartozzi
Published 2022-04-01
Article -
17
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial by Paolo A. Ascierto, Milena Casula, Jenny Bulgarelli, Marina Pisano, Claudia Piccinini, Luisa Piccin, Antonio Cossu, Mario Mandalà, Pier Francesco Ferrucci, Massimo Guidoboni, Piotr Rutkowski, Virginia Ferraresi, Ana Arance, Michele Guida, Evaristo Maiello, Helen Gogas, Erika Richtig, Maria Teresa Fierro, Celeste Lebbe, Hildur Helgadottir, Paola Queirolo, Francesco Spagnolo, Marco Tucci, Michele Del Vecchio, Maria Gonzales Cao, Alessandro Marco Minisini, Sabino De Placido, Miguel F. Sanmamed, Domenico Mallardo, Miriam Paone, Maria Grazia Vitale, Ignacio Melero, Antonio M. Grimaldi, Diana Giannarelli, Reinhard Dummer, Vanna Chiarion Sileni, Giuseppe Palmieri
Published 2024-01-01
Article